compound, process for preparing a compound, pharmaceutical formulation, use of a compound, methods of treating and / or preventing lipid disorders (dyslipidemia) associated or not with insulin resistance, and atherosclerosis, methods of treatment and / or prophylaxis of cardiovascular disease, hypercholesterolemia, conditions associated with the need to improve reverse cholesterol transport, and to decrease cholesterol absorption in the intestine, to increase HDL cholesterol levels, to lower cholesterol levels. ldl, inflammatory conditions, alzheimer's disease, type 2 diabetes arteriosclerosis, conditions associated with the need to improve hdl function, and pharmaceutical composition

摘要

"COMPOUND, PROCESS FOR THE PREPARATION OF A COMPOUND, PHARMACEUTICAL FORMULATION, USE OF A COMPOUND, METHODS OF TREATMENT AND / OR PREVENTION OF LIPID DISORDERS (DISLIPIDEMIA) ASSOCIATED OR NOT WITH INSULTATION AND INSULTATION RESISTANCE, OR PROFILAXY OF CARDIOVASCULAR DISEASE, HYPERCOLESTEROLEMIA, CONDITIONS ASSOCIATED WITH THE NEED TO IMPROVE REVERSE CHOLESTEROL TRANSPORT, AND TO DIMINATE COLESTEROL ABSORPTION IN THE INTESTINE OF NIN-SIMULAR DIMENSIONS LDL CHOLESTEROL OF INFLAMMATORY CONDITIONS, MAL ALZHEIMER, ARTERIOSCLEROSIS, TYPE 2 DIABETES, CONDITIONS ASSOCIATED WITH THE NEED TO IMPROVE HDL FUNCTION AND PHARMACEUTICAL COMPOSITION ". The invention relates to certain novel compounds of Formula (I): to processes for preparing them, to their utility in modulating Nuclear Receptor-Liver (LXR) 244 (NR1H3) and / or 225) hormone receptors (NR1H2) and in the treatment and / or prevention of clinical conditions including cardiovascular diseases such as atherosclerosis; inflammatory diseases, Alzheimer's disease, lipid disorders (dyslipidemias) associated or not with insulin resistance, type 2 diabetes and other manifestations of the metabolic syndrome, methods for their therapeutic use and pharmaceutical compositions containing them.